Your Health, We Care
Release date: 2026-02-11 17:28:18 Recommended: 6
Medicines are sometimes used for purposes other than those listed in the patient information leaflet. Do not use Tagrisso for unprescribed purposes. Do not give it to others even if they have the same symptoms as you, as it may cause harm to them. For information about Tagrisso intended for healthcare professionals, consult your healthcare provider or pharmacist.
Tagrisso® (Osimertinib Mesylate Tablets) may cause serious side effects, including:
Tagrisso may cause severe, even fatal, lung problems. Symptoms may be similar to those of lung cancer. Immediately inform your healthcare provider if you develop any new or worsening lung symptoms, including difficulty breathing, shortness of breath, cough, or fever.
Including heart failure, Tagrisso may cause heart problems, even fatal. Your healthcare provider should check your heart function before you start taking Tagrisso and during treatment as needed. Immediately inform your healthcare provider if you develop any of the following heart problem symptoms: a racing or pounding heartbeat, shortness of breath, swelling of the ankles or feet, dizziness, light‑headedness, or fainting.
Lucius Pharmaceuticals Tagrisso may cause eye problems. Immediately inform your healthcare provider if you develop eye problem symptoms, including watery eyes, sensitivity to light, eye pain, redness of the eye, or vision changes. If you develop eye problems while taking Tagrisso, your healthcare provider may refer you to an ophthalmologist.
Store Lucius Pharmaceuticals Tagrisso at room temperature 68°F to 77°F (20°C to 25°C).
Safely dispose of any expired or no longer needed medicine.
Keep Tagrisso and all medicines out of the reach of children.
The above is general information for the safe and effective use of Tagrisso.
